ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel
  • »
  • Health»
  • Personal Health Information & Self-Help

A dangerous alliance between obesity and insulin resistance

Updated on April 6, 2015

According to the statistics of World Health Organization, in 2008, 34% of men and 35% of women aged 20+ were overweight (BMI ≥ 25 kg/m2). The worldwide prevalence of obesity has nearly doubled between 1980 and 2008. In 2008, 10% of men and 14% of women in the world were obese (BMI ≥30 kg/m2), compared with 5% for men and 8% for women in 1980. Since obesity is linked with insulin resistance, the current trends of obesity will correspondingly increase the prevalence of insulin resistance worldwide. Undoubtedly, an epidemic of obesity-insulin resistance-type-2diabtes has taken over the world. Surprisingly, the statistics indicate that worldwide at least 2.8 million people die each year as a result of being overweight or obese.

It has been well established that there exists an association between body weight and development of insulin resistance. The persons, who are overweight or obese, are more likely to develop insulin resistance, which is precursor to type-2 diabetes. Central obesity, commonly called potbelly, is also known to predispose the individuals to insulin resistance even if they have normal weight. Central obesity may, therefore, lead to type-2 diabetes.

Underlying mechanism –

In obese individuals, fat primarily white adipose tissue (WAT) releases increased amounts of hormones, pro-inflammatory cytokines and other factors that are involved in the development of insulin resistance. When insulin resistance is accompanied by dysfunction of pancreatic islet β-cells that release insulin, blood glucose levels rise. Therefore, abnormalities in pancreatic β-cell function are critical in defining the risk and development of type 2 diabetes.

A study in 1993 showed a link between obesity and inflammation, demonstrating that the pro-inflammatory cytokine tumor-necrosis factor (TNF)-α was expressed in adipose tissue of obese mice and linked to insulin resistance (IR).

White adipose tissue (WAT) is primarily associated with insulin resistance in humans. Obesity-associated inflammation starts in adipose tissue and liver with elevated macrophage infiltration and expression of pro-inflammatory cytokines. The pro-inflammatory cytokines enter the blood stream to cause systemic inflammation. In obesity, chronic inflammation has many detrimental effects in the body. And one of its detrimental effects is development of insulin resistance.

It has been found that central obesity raises serum resistin levels in the body, which directly co-relates to insulin resistance. Studies also validate a direct co-relation between resistin levels and type-2 diabetes. Central obesity seems to be the foremost type of fat deposits contributing to rising levels of serum resistin. Conversely, serum resistin levels have been found to decline with decreased adiposity following its management.

Conclusion –

Worldwide statistics reveal that prevalence of obesity is steadily increasing all over the world. And since obesity undoubtedly causes insulin resistance, which is turn may lead to type-2 diabetes.

According to reliable projections of the prevalence of type-2 diabetes, it is assumed that total diabetes cases, diagnosed and undiagnosed, will increase from 14% in 2010 to 21% of the US adult population by 2050. These projections are largely attributable to aging population that has a higher risk of insulin resistance. And, moreover, older people are living longer these days. The scenario of prevalence of type-2 diabetes is more or less the same in the developed and in some of the developing nations.

It will not be an exaggeration to say that the nexus of obesity, insulin resistance and type-2 diabetes is epidemically prevalent worldwide. If this nexus is not broken in time, notwithstanding other harmful effects of obesity, there will a big surge in the prevalence type-2 diabetes and its associated co-morbidities.


Comments

    0 of 8192 characters used
    Post Comment

    No comments yet.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: "https://hubpages.com/privacy-policy#gdpr"

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)